Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Sanofi/Takeda, UniQure & CSL, Fog Pharma, Merck + Imago
-
Lu par :
-
De :
À propos de ce contenu audio
Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Sanofi/Takeda
UniQure & CSL
Fog Pharma
Merck + Imago
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
